Keeping Track: US FDA Greenlights Two More Novel Drugs, But Smacks Down Golodirsen

 
• By Michael Cipriano, Bridget Silverman, and Brenda Sandburg
  
Keeping Track Feature image
The FDA approved Xenleta and Ga-68-DOTATOC but issued a complete response letter for golodirsen.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approvals

More from Product Reviews